| 1 |
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
Barry Morton Brenner, Mark Emmanuel Cooper, Dick de Zeeuw et al. · New England Journal of Medicine
Open access |
20 Sep 2001 |
7,554 |
| 2 |
Genetic studies of body mass index yield new insights for obesity biology
The LifeLines Cohort Study et al. · Nature
Open access487 authors |
10 Feb 2015 |
4,954 |
| 3 |
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
Peter Gæde, Pernille Nygaard Vedel, Nicolai Balle Larsen et al. · New England Journal of Medicine
Open access |
29 Jan 2003 |
4,419 |
| 4 |
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino et al. · Diabetes Care
Open access |
8 Jun 2019 |
4,012 |
| 5 |
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies, David A. D’Alessio, JUDITH E. FRADKIN et al. · Diabetes Care
Open access |
5 Oct 2018 |
3,565 |
| 6 |
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
Peter Gæde, Henrik Lund‐Andersen, Hans‐Henrik Parving et al. · New England Journal of Medicine
Open access |
6 Feb 2008 |
3,489 |
| 7 |
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index
MAGIC et al. · Nature Genetics
Open access376 authors |
10 Oct 2010 |
2,999 |
| 8 |
The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes
Hans-Henrik Parving, Hendrik Lehnert, Jens Brøchner‐Mortensen et al. · New England Journal of Medicine
|
20 Sep 2001 |
2,903 |
| 9 |
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
George L. Bakris, Rajiv Agarwal, Stefan D. Anker et al. · New England Journal of Medicine
Open access |
23 Oct 2020 |
2,875 |
| 10 |
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Daniel J. Klionsky et al. · Autophagy
Open access2,930 authors |
2 Jan 2021 |
2,743 |
| 11 |
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Hans‐Henrik Parving, Hendrik Lehnert, Jens Brøchner‐Mortensen et al. · PubMed
|
Oct 2001 |
2,531 |
| 12 |
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk
Josée Dupuis et al. · Nature Genetics
Open access263 authors |
17 Jan 2010 |
2,239 |
| 13 |
Human gut microbes impact host serum metabolome and insulin sensitivity
Helle Pedersen et al. · Nature
Open access |
Jul 2016 |
2,204 |
| 14 |
Defining the role of common variation in the genomic and biological architecture of adult human height
Andrew R. Wood et al. · Nature Genetics
446 authors |
5 Oct 2014 |
2,114 |
| 15 |
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies, Vanita R. Aroda, Billy S. Collins et al. · Diabetes Care
Open access |
23 Sep 2022 |
2,099 |
| 16 |
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Mansoor Husain, Andreas L. Birkenfeld, Morten Donsmark et al. · New England Journal of Medicine
Open access |
11 Jun 2019 |
2,006 |
| 17 |
Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps
Anubha Mahajan et al. · Nature Genetics
Open access115 authors |
Oct 2018 |
1,968 |
| 18 |
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes
Eleftheria Zeggini et al. · Nature Genetics
ReviewOpen access |
30 Mar 2008 |
1,880 |
| 19 |
Translating the A1C Assay Into Estimated Average Glucose Values
David M. Nathan, Judith C. Kuenen, Rikke Borg et al. · Diabetes Care
Open access |
8 Jun 2008 |
1,854 |
| 20 |
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
Vlado Perkovic, Katherine R. Tuttle, Peter R Rossing et al. · New England Journal of Medicine
|
24 May 2024 |
1,815 |
| 21 |
Interleukin-1–Receptor Antagonist in Type 2 Diabetes Mellitus
Claus Morten Larsen, Mirjam V. Faulenbach, Allan Arthur Vaag et al. · New England Journal of Medicine
Open access |
11 Apr 2007 |
1,813 |
| 22 |
Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes
Jeffrey C. Barrett, David G Clayton, PATRICK J. CONCANNON et al. · Nature Genetics
Open access |
10 May 2009 |
1,787 |
| 23 |
New genetic loci link adipose and insulin biology to body fat distribution
Dmitry Shungin et al. · Nature
Open access410 authors |
10 Feb 2015 |
1,726 |
| 24 |
Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3)
Kazuya Yamagata et al. · Nature
|
Dec 1996 |
1,627 |
| 25 |
Genome-wide association study identifies 74 loci associated with educational attainment
Aysu Okbay et al. · Nature
Open access256 authors |
10 May 2016 |
1,500 |
| 26 |
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies, David A. D’Alessio, JUDITH E. FRADKIN et al. · Diabetologia
Open access |
4 Oct 2018 |
1,474 |
| 27 |
Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity
Guðmar Þorleifsson et al. · Nature Genetics
Open access |
14 Dec 2008 |
1,416 |
| 28 |
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
Caroline S. Fox, Kunihiro Matsushita, Mark Woodward et al. · The Lancet
ReviewOpen access |
23 Sep 2012 |
1,413 |
| 29 |
Single‐cell RNA sequencing technologies and applications: A brief overview
Dragomirka Jovic, Xue Liang, Hua Zeng et al. · Clinical and Translational Medicine
Open access |
Mar 2022 |
1,350 |
| 30 |
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
Peter R Rossing, Maria Luiza Caramori, Juliana C.N. Chan et al. · Kidney International
Open access |
19 Oct 2022 |
1,333 |
| 31 |
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
Hans‐Henrik Parving, Barry Morton Brenner, John J.V. McMurray et al. · New England Journal of Medicine
Open access |
3 Nov 2012 |
1,332 |
| 32 |
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
Rajiv Agarwal, Gerasimos S Filippatos, Bertram Pitt et al. · European Heart Journal
Open access |
Nov 2021 |
1,295 |
| 33 |
Diabetic kidney disease
Merlin C. Thomas, Michael Brownlee, Katalin Suszták et al. · Nature Reviews Disease Primers
ReviewOpen access |
30 Jul 2015 |
1,256 |
| 34 |
The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes
Aleksandar David Kostic et al. · Cell Host & Microbe
Open access |
Feb 2015 |
1,242 |
| 35 |
Integrative analysis of multimodal mass spectrometry data in MZmine 3
Robin Schmid et al. · Nature Biotechnology
Open access |
Mar 2023 |
1,241 |
| 36 |
2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
John B. Buse, Deborah J. Wexler, Απόστολος Τσάπας et al. · Diabetes Care
Open access |
19 Dec 2019 |
1,208 |
| 37 |
Global healthcare expenditure on diabetes for 2010 and 2030
Ping Zhang, Xinzhi Zhang, Jonathan Betz Brown et al. · Diabetes Research and Clinical Practice
|
20 Feb 2010 |
1,150 |
| 38 |
Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses
LifeLines Cohort Study et al. · Nature Genetics
Open access188 authors |
18 Apr 2016 |
1,144 |
| 39 |
The genetic architecture of type 2 diabetes
Christian Fuchsberger et al. · Nature
Open access301 authors |
11 Jul 2016 |
1,129 |
| 40 |
Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
Hans‐Henrik Parving, Frederik Persson, Julia Breyer Lewis et al. · New England Journal of Medicine
Open access |
4 Jun 2008 |
1,105 |
| 41 |
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes
Valgerður Steinthórsdóttir et al. · Nature Genetics
Open access |
26 Apr 2007 |
1,090 |
| 42 |
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies, Vanita R. Aroda, Billy S. Collins et al. · Diabetologia
Open access |
23 Sep 2022 |
1,060 |
| 43 |
The double burden of malnutrition: aetiological pathways and consequences for health
Jonathan C. K. Wells, Ana Lydia Sawaya, Rasmus Wibæk et al. · The Lancet
Open access |
15 Dec 2019 |
998 |
| 44 |
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study
Peter Gæde, Pernille Nygaard Vedel, Hans‐Henrik Parving et al. · The Lancet
|
Feb 1999 |
996 |
| 45 |
Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution
MAGIC et al. · Nature Genetics
301 authors |
10 Oct 2010 |
965 |
| 46 |
A catalog of genetic loci associated with kidney function from analyses of a million individuals
Lifelines Cohort Study et al. · Nature Genetics
Open access329 authors |
31 May 2019 |
946 |
| 47 |
A saturated map of common genetic variants associated with human height
Loïc Yengo et al. · Nature
Open access632 authors |
12 Oct 2022 |
934 |
| 48 |
A Taql polymorphism in the human interleukin‐1β (IL‐1β) gene correlates with IL‐1β secretion in vitro
Flemming Pociot, Jens Mølvig, Lise Wogensen et al. · European Journal of Clinical Investigation
|
Jun 1992 |
922 |
| 49 |
The trans-ancestral genomic architecture of glycemic traits
Jihua Chen et al. · Nature Genetics
Open access417 authors |
31 May 2021 |
918 |
| 50 |
Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)
Ian H. de Boer, Kamlesh K. Khunti, Tami Sadusky et al. · Diabetes Care
Open access |
3 Oct 2022 |
913 |